In this comprehensive volume dedicated to systemic lupus erythematosus (SLE) and Sjögren syndrome, leading specialists from diverse medical fields present the latest research findings and cutting-edge trends in treatment, including the innovative “treat to target” approach. This essential resource bridges basic science and clinical medicine, highlighting the most promising studies that are shaping the future of these conditions.
Readers will benefit from a wide-ranging exploration of key topics such as epidemiology, pathogenesis, autoantibodies and biomarkers, and the varied disease manifestations. The book thoroughly examines the involvement of different organs or systems, the relationships with other disorders, and the advancements in biological therapy for SLE and systemic treatment of Sjögren syndrome.
Why should you read this book? If you are a medical professional, researcher, or student seeking an authoritative source on SLE and Sjögren syndrome, this volume will enhance your understanding and inform your clinical practice with the most current knowledge. The expert insights and comprehensive scope make it an indispensable addition to medical libraries and personal collections alike.
What makes this book special? As the first volume of the Connective Tissue Disease series, it offers a profound overview that clearly conveys the significant progress made in recent years, positioning itself as a cornerstone in understanding and managing these complex conditions.
Discover the latest breakthroughs and equip yourself with the knowledge to make informed decisions in the treatment of SLE and Sjögren syndrome.
Authors:
Dario Roccatello (Editor)
Edition:
1st ed. 2016
Publication Date:
April 9, 2016
Reviews
There are no reviews yet.